← Back to Search

Other

Zinc Amino Acid for Zinc Deficiency

N/A

Recruiting

Research Sponsored by University of California, Berkeley

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 (baseline 1), day 15 (endpoint 1), day 29 (baseline 2), day 43 (endpoint 2)

Awards & highlights

Study Summary

This trial aims to study how the body processes zinc from food and supplements. The researchers believe that zinc from food is directed to the liver, while zinc from supplements goes into the bloodstream. They think that

Who is the study for?

This trial is for individuals who can safely take zinc supplements without risk of toxicity. Participants must be able to consume the supplements in a fasted state over a period of 13 days.Check my eligibility

What is being tested?

The study compares the metabolic effects of two different forms of zinc supplementation: Zinc-Amino Acid (ZnAA) complex and Zinc Gluconate, taken without food to see which is better absorbed and utilized by the body.See study design

What are the potential side effects?

Potential side effects may include signs of zinc toxicity such as nausea, vomiting, loss of appetite, stomach cramps, diarrhea, and headaches.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 (baseline 1), day 15 (endpoint 1), day 29 (baseline 2), day 43 (endpoint 2)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 (baseline 1), day 15 (endpoint 1), day 29 (baseline 2), day 43 (endpoint 2)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (baseline 1), day 15 (endpoint 1), day 29 (baseline 2), day 43 (endpoint 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

FADS1 activity index

Secondary outcome measures

Fasted plasma zinc concentration

Trial Design

2Treatment groups

Experimental Treatment

Group I: Zinc GluconateExperimental Treatment1 Intervention

The zinc in the supplement is complexed with gluconate.

Group II: Zinc Amino AcidExperimental Treatment1 Intervention

The zinc in the supplement is complexed with the amino acids lysine and glutamate.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, BerkeleyLead Sponsor

181 Previous Clinical Trials

721,126 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the clinical trial inclusive of participants who are younger than 20 years old?

"Eligible participants for this research study must be above 18 years of age but under the age of 50."

Answered by AI

What are the eligibility criteria for individuals who can participate in this medical research study?

"To be eligible for this research, individuals must exhibit excessive levels of zinc in their body and fall within the age bracket of 18 to 50. The study is open to approximately 30 participants."

Answered by AI

Are there any ongoing efforts to enlist participants for this trial?

"As per clinicaltrials.gov, this investigation is actively enrolling volunteers. The trial was first listed on 1/22/2024 and underwent its latest update on 3/29/2024."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate

2024. "A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06348056.

All > Sacramento